The Manufacturers Life Insurance Company bought a new stake in shares of Clarivate Plc (NYSE:CLVT) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 91,823 shares of the company’s stock, valued at approximately $2,528,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Clarivate in the second quarter valued at approximately $476,734,000. Bank of New York Mellon Corp bought a new position in shares of Clarivate in the 2nd quarter valued at $171,113,000. Eagle Asset Management Inc. acquired a new position in shares of Clarivate during the 2nd quarter worth $72,066,000. Artisan Partners Limited Partnership bought a new stake in shares of Clarivate during the 2nd quarter worth $51,359,000. Finally, Deutsche Bank AG acquired a new stake in Clarivate in the second quarter valued at about $22,155,000. 71.58% of the stock is currently owned by institutional investors.
Shares of NYSE:CLVT opened at $21.38 on Thursday. The firm has a market cap of $13.73 billion, a P/E ratio of -82.23, a P/E/G ratio of 3.72 and a beta of 0.61. Clarivate Plc has a 12-month low of $20.31 and a 12-month high of $34.79. The business has a fifty day simple moving average of $23.56 and a 200 day simple moving average of $25.65. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.34.
Several equities research analysts recently issued reports on CLVT shares. Zacks Investment Research raised shares of Clarivate from a “sell” rating to a “hold” rating in a report on Tuesday, October 5th. Morgan Stanley dropped their price target on Clarivate from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Thursday, September 30th. Finally, Bank of America initiated coverage on Clarivate in a report on Monday, August 16th. They issued a “buy” rating and a $28.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Clarivate presently has an average rating of “Buy” and a consensus price target of $30.83.
Clarivate Company Profile
Clarivate Plc engages in the provision of trusted insights and analytics to accelerate the pace of innovation. It operates through the Science and Intellectual Property segments. The Science segment comprises the academic and life science product lines. The Intellectual Property segment includes patent, trademark, domain, and IP management product lines.
Featured Story: Growth Stocks
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVT).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.